Neogen Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $19.54
- Today's High:
- $20.52
- Open Price:
- $19.68
- 52W Low:
- $10.49
- 52W High:
- $24.1
- Prev. Close:
- $19.82
- Volume:
- 2293286
Company Statistics
- Market Cap.:
- $4.29 billion
- Book Value:
- 14.494
- Revenue TTM:
- $822.45 million
- Operating Margin TTM:
- 12.03%
- Gross Profit TTM:
- $409.20 million
- Profit Margin:
- -2.78%
- Return on Assets TTM:
- 2.23%
- Return on Equity TTM:
- -1.14%
Company Profile
Neogen Corporation had its IPO on 1989-08-23 under the ticker symbol NEOG.
The company operates in the Healthcare sector and Diagnostics & Research industry. Neogen Corporation has a staff strength of 2,640 employees.
Stock update
Shares of Neogen Corporation opened at $19.68 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $19.54 - $20.52, and closed at $20.52.
This is a +3.53% increase from the previous day's closing price.
A total volume of 2,293,286 shares were traded at the close of the day’s session.
In the last one week, shares of Neogen Corporation have slipped by -12.04%.
Neogen Corporation's Key Ratios
Neogen Corporation has a market cap of $4.29 billion, indicating a price to book ratio of 3.7534 and a price to sales ratio of 6.1553.
In the last 12-months Neogen Corporation’s revenue was $822.45 million with a gross profit of $409.20 million and an EBITDA of $187.31 million. The EBITDA ratio measures Neogen Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Neogen Corporation’s operating margin was 12.03% while its return on assets stood at 2.23% with a return of equity of -1.14%.
In Q1.6666666666667, Neogen Corporation’s quarterly earnings growth was a negative -81.4% while revenue growth was a positive 72.6%.
Neogen Corporation’s PE and PEG Ratio
- Forward PE
- 16
- Trailing PE
- 0
- PEG
- 0.6575
Its diluted EPS in the last 12-months stands at $-0.12 per share while it has a forward price to earnings multiple of 16 and a PEG multiple of 0.6575. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Neogen Corporation’s profitability.
Neogen Corporation stock is trading at a EV to sales ratio of 5.5902 and a EV to EBITDA ratio of 44.5369. Its price to sales ratio in the trailing 12-months stood at 6.1553.
Neogen Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $4.55 billion
- Total Liabilities
- $145.47 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $25.50 million
- Dividend Payout Ratio
- 0%
Neogen Corporation ended 2024 with $4.55 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $4.55 billion while shareholder equity stood at $3.13 billion.
Neogen Corporation ended 2024 with $0 in deferred long-term liabilities, $145.47 million in other current liabilities, 34599000.00 in common stock, $565.04 million in retained earnings and $3.77 billion in goodwill. Its cash balance stood at $163.24 million and cash and short-term investments were $245.57 million. The company’s total short-term debt was $0 while long-term debt stood at $885.44 million.
Neogen Corporation’s total current assets stands at $585.93 million while long-term investments were $0 and short-term investments were $82.33 million. Its net receivables were $153.25 million compared to accounts payable of $76.67 million and inventory worth $133.81 million.
In 2024, Neogen Corporation's operating cash flow was $0 while its capital expenditure stood at $25.50 million.
Comparatively, Neogen Corporation paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $20.52
- 52-Week High
- $24.1
- 52-Week Low
- $10.49
- Analyst Target Price
- $20.5
Neogen Corporation stock is currently trading at $20.52 per share. It touched a 52-week high of $24.1 and a 52-week low of $24.1. Analysts tracking the stock have a 12-month average target price of $20.5.
Its 50-day moving average was $22.32 and 200-day moving average was $19.01 The short ratio stood at 11.18 indicating a short percent outstanding of 0%.
Around 9.1% of the company’s stock are held by insiders while 10279.3% are held by institutions.
Frequently Asked Questions About Neogen Corporation
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.